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CORRESPONDENCE
Stand-by treatment of sepsis in people without a
spleen
In their review of the management of infections in
patients without a spleen, Davidson and Wall
recommend co-amoxiclav 625mg 8-hourly or
cefuroxime 250mg 12-hourly for standby treat-
ment of early suspected post-splenectomy infec-
tion [1]. 1 do not believe that this is sufﬁcient
standby treatment for the early symptoms of an
illness that may progress to overwhelming post-
splenectomy infection (OPSI). My recommenda-
tion would be a starting dose of amoxicillin 3 g
followed by 1 g 8-hourly.
It iswellknownthattheearlysymptomsandsigns
ofOPSImaybeverynon-speciﬁc—oftenresembling
a ﬂu-like illness—and may coincide with already
irreversible physiologic damage [2]. However,
prompt and potent antibiotic therapy may be life-
saving and may prevent serious morbidity. Why
give 500mg of amoxicillin when 3 g is likely to be
moreeffectiveandisalsoknowntobewelltolerated?
While all would agree that prompt medical atten-
tion is crucial, delays in management do occur—
particularly when people are traveling and/or on
vacation.Given thatOPSI still occursdespite immu-
nization and/or prophylactic antibiotics [3–8],
asplenic individualsmustbegiventhebestavailable
advice for the management of febrile illnesses.
An additional issue is the choice of co-amoxiclav
itself. Given that Streptococcus pneumoniae accounts
for around 90% of cases of OPSI [2], there is little
to be gained by the addition of clavulanate to
amoxicillin. Although resistance to penicillins in
S. pneumoniae is emerging, it is not mediated by
b-lactamases.
Note from the Editor: Dr Davidson and Dr Wall
did not choose to respond to this letter.
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